Niquitin Mini Citrus (Nicotine)

Nicotine in the lozenge binds to nicotinic acetylcholine receptors in the brain, stimulating dopamine release and mimicking the rewarding effects of smoking. This reduces cravings and withdrawal symptoms, allowing the user to gradually lower nicotine intake while avoiding exposure to the harmful constituents of tobacco smoke.

The appropriate dose is determined by a healthcare professional based on the individual’s smoking history, level of dependence, and previous quit‑attempts. The prescriber will select the strength and frequency that best matches the patient’s needs and will provide instructions for safe use.

The safety of nicotine lozenges during pregnancy or lactation has not been established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternative cessation strategies with their healthcare provider before using this product.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with nicotine gum, the lozenge provides a slower, more gradual release of nicotine, which can be gentler on the throat and may reduce the likelihood of oral irritation. Unlike transdermal patches, the lozenge allows flexible dosing throughout the day, making it easier to adjust nicotine intake based on cravings.

Store the lozenges at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and direct sunlight. Keep out of reach of children and do not use if the package is damaged or the product appears discolored.

The lozenge is placed in the mouth and allowed to dissolve slowly, moving it occasionally from one side of the mouth to the other. Do not chew or swallow whole. Use the product as directed by a healthcare professional, typically every 1–2 hours during the first days of a quit attempt, and gradually reduce frequency.

Serious adverse events, although rare, include allergic reactions such as rash, swelling, or difficulty breathing, as well as chest pain or irregular heart rhythms. If any of these symptoms occur, discontinue use immediately and seek medical attention.

Individuals with known hypersensitivity to nicotine or any excipients in the lozenge should avoid it. It is also contraindicated for patients using other nicotine replacement products simultaneously, and caution is advised for those with uncontrolled hypertension, recent myocardial infarction, or severe cardiac arrhythmias.